Once-daily, single-inhaler mometasone–indacaterol–glycopyrronium versus mometasone–indacaterol or twice-daily fluticasone–salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study-Reference-Cited by-同舟云学术

Once-daily, single-inhaler mometasone–indacaterol–glycopyrronium versus mometasone–indacaterol or twice-daily fluticasone–salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study

Published:2020-10 Issue:10 Volume:8 Page:1000-1012
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Kerstjens Huib A M,Maspero Jorge,Chapman Kenneth R,van Zyl-Smit Richard N,Hosoe Motoi,Tanase Ana-Maria,Lavecchia Catherine,Pethe Abhijit,Shu Xu,D'Andrea Peter

Funder

Chiesi Farmaceutici

Novartis Pharmaceuticals Canada

Novartis

Boehringer Ingelheim

GlaxoSmithKline

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference28 articles.

1. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma controL study;Bateman;Am J Respir Crit Care Med,2004

2. Understanding patients with asthma and COPD: insights from a European study;Partridge;Prim Care Respir J,2011

3. Prevalence of asthma control among adults in France, Germany, Italy, Spain and the UK;Demoly;Eur Respir Rev,2009

4. Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma;Kew;Cochrane Database Syst Rev,2016

5. Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study);Munoz-Cano;Eur Respir J,2017

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of Moderate and Severe Asthma Exacerbations in the CAPTAIN Study;The Journal of Allergy and Clinical Immunology: In Practice;2024-09

2. Therapeutic effect of long-acting muscarinic antagonist for treating uncontrolled asthma assessed using impulse oscillometry;Respiratory Research;2024-08-07

3. Use of Triple Therapy in Asthma: The GEMAFORUM V Task Force;Journal of Investigational Allergology and Clinical Immunology;2024-07-30

4. Real-world characteristics of patients with asthma initiating fluticasone furoate/umeclidinium/vilanterol single-inhaler triple therapy in Japan;Respiratory Investigation;2024-07

5. Expert opinion on diagnosis and management of Severe Asthma in low and middle income countries (LMIC) with focus on India;Journal of Asthma;2024-06-19